Analysis of 110 Cases of Adverse Reactions and Risk Factors Induced by Moxifloxacin

Chen Chunyan, Shan Huiting, Zhao Haixia, Ding Nan, Xiong Daiqin

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (4) : 456-461.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (4) : 456-461. DOI: 10.16153/j.1002-7777.2021.04.014
Rational Medication

Analysis of 110 Cases of Adverse Reactions and Risk Factors Induced by Moxifloxacin

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(4): 456-461 https://doi.org/10.16153/j.1002-7777.2021.04.014

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉